Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Hsu PY, Cheng TS, Chuang SC, Chang WT, Liang PC, Hsu CT, Wei YJ, Jang TY, Yeh ML, Huang CI, Lin YH, Wang CW, Hsieh MY, Hou NJ, Hsieh MH, Tsai YS, Ko YM, Lin CC, Chen KY, Dai CY, Lin ZY, Chen SC, Huang JF, Chuang WL, Huang CF, Yu ML.
Hsu PY, et al. Among authors: wang cw.
Cancer Med. 2022 Jan;11(1):104-116. doi: 10.1002/cam4.4430. Epub 2021 Nov 16.
Cancer Med. 2022.
PMID: 34786871
Free PMC article.